These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
6. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects. Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987 [TBL] [Abstract][Full Text] [Related]
7. APOE effects on regional tau in preclinical Alzheimer's disease. Young CB; Johns E; Kennedy G; Belloy ME; Insel PS; Greicius MD; Sperling RA; Johnson KA; Poston KL; Mormino EC; ; Mol Neurodegener; 2023 Jan; 18(1):1. PubMed ID: 36597122 [TBL] [Abstract][Full Text] [Related]
8. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden. Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551 [TBL] [Abstract][Full Text] [Related]
9. Initial levels of β-amyloid and tau deposition have distinct effects on longitudinal tau accumulation in Alzheimer's disease. Cai Y; Du J; Li A; Zhu Y; Xu L; Sun K; Ma S; Guo T; Alzheimers Res Ther; 2023 Feb; 15(1):30. PubMed ID: 36750884 [TBL] [Abstract][Full Text] [Related]
10. Tau Accumulation in Clinically Normal Older Adults Is Associated with Hippocampal Hyperactivity. Huijbers W; Schultz AP; Papp KV; LaPoint MR; Hanseeuw B; Chhatwal JP; Hedden T; Johnson KA; Sperling RA J Neurosci; 2019 Jan; 39(3):548-556. PubMed ID: 30482786 [TBL] [Abstract][Full Text] [Related]
11. Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age. Betthauser TJ; Koscik RL; Jonaitis EM; Allison SL; Cody KA; Erickson CM; Rowley HA; Stone CK; Mueller KD; Clark LR; Carlsson CM; Chin NA; Asthana S; Christian BT; Johnson SC Brain; 2020 Jan; 143(1):320-335. PubMed ID: 31886494 [TBL] [Abstract][Full Text] [Related]
12. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β. Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's pathology targets distinct memory networks in the ageing brain. Maass A; Berron D; Harrison TM; Adams JN; La Joie R; Baker S; Mellinger T; Bell RK; Swinnerton K; Inglis B; Rabinovici GD; Düzel E; Jagust WJ Brain; 2019 Aug; 142(8):2492-2509. PubMed ID: 31199481 [TBL] [Abstract][Full Text] [Related]
14. Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia. Lowe VJ; Wiste HJ; Senjem ML; Weigand SD; Therneau TM; Boeve BF; Josephs KA; Fang P; Pandey MK; Murray ME; Kantarci K; Jones DT; Vemuri P; Graff-Radford J; Schwarz CG; Machulda MM; Mielke MM; Roberts RO; Knopman DS; Petersen RC; Jack CR Brain; 2018 Jan; 141(1):271-287. PubMed ID: 29228201 [TBL] [Abstract][Full Text] [Related]
15. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease. Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA; Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519 [TBL] [Abstract][Full Text] [Related]
16. Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease. Young CB; Winer JR; Younes K; Cody KA; Betthauser TJ; Johnson SC; Schultz A; Sperling RA; Greicius MD; Cobos I; Poston KL; Mormino EC; JAMA Neurol; 2022 Jun; 79(6):592-603. PubMed ID: 35435938 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal Evolution of Financial Capacity and Cerebral Tau and Amyloid Burden in Older Adults with Normal Cognition or Mild Cognitive Impairment. Mimmack KJ; Sprague EH; Amariglio RE; Vannini P; Marshall GA J Prev Alzheimers Dis; 2024; 11(4):966-974. PubMed ID: 39044507 [TBL] [Abstract][Full Text] [Related]
18. Widespread distribution of tauopathy in preclinical Alzheimer's disease. Schultz SA; Gordon BA; Mishra S; Su Y; Perrin RJ; Cairns NJ; Morris JC; Ances BM; Benzinger TLS Neurobiol Aging; 2018 Dec; 72():177-185. PubMed ID: 30292840 [TBL] [Abstract][Full Text] [Related]
19. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults. Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078 [TBL] [Abstract][Full Text] [Related]